Pasque Flower (Pulsatilla vulgaris)

Pasque flower (Pulsatilla vulgaris) contains ranunculin and protoanemonin compounds that exhibit anticancer and spasmolytic properties. Research shows it may inhibit cervical cancer cell growth by deregulating 12 cellular signaling pathways.

Origin & History

Pasque Flower (Pulsatilla vulgaris) is a perennial herb native to Europe, from Great Britain to Ukraine, belonging to the Ranunculaceae family. The medicinal form is sourced from dried aerial parts (flowers, leaves, roots), as fresh material contains toxic ranunculin that converts to protoanemonin when crushed. Extraction involves careful drying to reduce toxicity or solvent extraction to isolate triterpenoid saponins and phenolic acids.

Historical & Cultural Context

Pasque Flower has been used in European traditional herbalism for over a century, with U.S.P. descriptions dating to early 20th-century eclectic medicine. Historically valued for its spasmolytic properties, it was traditionally prescribed for nervous system disorders, menstrual issues, and respiratory spasms, always using dried forms due to fresh plant toxicity.

Health Benefits

• May inhibit cervical cancer cell growth through deregulation of 12 signaling pathways (preliminary in-vitro evidence only)
• Traditional use for menstrual disorders and nervous system conditions (no clinical trials available)
• Spasmolytic properties for respiratory spasms (traditional use, no human studies)
• Potential apoptosis induction in cancer cells via triterpenoid saponins (in-vitro study only)
• Historical use for nervous system disorders (traditional evidence only, no RCTs)

How It Works

Pasque flower's primary bioactive compounds ranunculin and protoanemonin modulate cellular signaling pathways including apoptosis and cell cycle regulation. The plant deregulates 12 specific pathways in cancer cells, including p53, MAPK, and PI3K/Akt signaling cascades. Protoanemonin also exhibits direct smooth muscle relaxant effects on respiratory tissues.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Pasque Flower. The only available research is one in-vitro study (PMC9860614) demonstrating that root and leaf extracts inhibited 12 signaling pathways in cervical cancer cell lines through triterpenoid saponins and phenolic acids. All evidence remains at the preclinical level.

Clinical Summary

Current evidence for pasque flower is limited to preliminary in-vitro studies on cervical cancer cells, showing growth inhibition through pathway modulation. No human clinical trials have been conducted to validate traditional uses for menstrual disorders or respiratory conditions. Safety and efficacy data in humans remains absent, with only historical traditional medicine documentation available. Research is insufficient to establish therapeutic dosing or clinical applications.

Nutritional Profile

{"macronutrients": {"protein": "Not significant", "fiber": "Not significant"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts"}, "minerals": {"Calcium": "Trace amounts", "Potassium": "Trace amounts"}}, "bioactive_compounds": {"triterpenoid_saponins": "Present, specific concentration not well-documented", "flavonoids": "Present, specific concentration not well-documented"}, "bioavailability_notes": "The bioavailability of the compounds is not well-studied, and concentrations can vary based on the plant's growing conditions and preparation methods."}

Preparation & Dosage

No clinically studied dosage ranges exist as human trials are absent. Fresh plant material is toxic and must be avoided internally. Only dried aerial parts should be used under qualified practitioner supervision. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not established - no clinical studies on combinations

Safety & Interactions

Fresh pasque flower contains irritant compounds that can cause skin and mucous membrane irritation upon direct contact. The plant may interact with anticoagulant medications due to potential bleeding risk effects. Pregnant and breastfeeding women should avoid use due to traditional associations with uterine stimulation and lack of safety data. Dried preparations are generally considered safer than fresh plant material, but professional guidance is recommended.